133 related articles for article (PubMed ID: 1932937)
1. Compulsive personality as predictor of response to serotoninergic antidepressants.
Ansseau M; Troisfontaines B; Papart P; von Frenckell R
BMJ; 1991 Sep; 303(6805):760-1. PubMed ID: 1932937
[No Abstract] [Full Text] [Related]
2. Serotonin selectivity for obsessive compulsive and panic disorders.
Montgomery SA; Bullock T; Fineberg N
J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
[No Abstract] [Full Text] [Related]
3. Serotonergic antidepressants and obsessive-compulsive disorder.
Cialdella P; Boissel JP
Am J Psychiatry; 1991 Oct; 148(10):1415-6. PubMed ID: 1832819
[No Abstract] [Full Text] [Related]
4. Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study.
Mundo E; Guglielmo E; Bellodi L
Int Clin Psychopharmacol; 1998 Sep; 13(5):219-24. PubMed ID: 9817627
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.
McDougle CJ; Goodman WK; Price LH; Delgado PL; Krystal JH; Charney DS; Heninger GR
Am J Psychiatry; 1990 May; 147(5):652-4. PubMed ID: 1970224
[TBL] [Abstract][Full Text] [Related]
6. [The role of drugs in the treatment of obsessive-compulsive disorders].
den Boer JA; Westenberg HG
Ned Tijdschr Geneeskd; 1990 Mar; 134(10):503-4. PubMed ID: 2107405
[No Abstract] [Full Text] [Related]
7. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J
Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
[TBL] [Abstract][Full Text] [Related]
8. A seizure, and electroencephalographic signs of a lowered seizure threshold, associated with fluvoxamine treatment of obsessive-compulsive disorder.
Trabert W; Hohagen F; Winkelmann G; Berger M
Pharmacopsychiatry; 1995 May; 28(3):95-7. PubMed ID: 7568372
[TBL] [Abstract][Full Text] [Related]
9. [Drug treatment of compulsive disorder].
Rapoport JL
Nervenarzt; 1991 May; 62(5):318-20. PubMed ID: 1865964
[No Abstract] [Full Text] [Related]
10. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.
McDougle CJ; Price LH; Goodman WK; Charney DS; Heninger GR
J Clin Psychopharmacol; 1991 Jun; 11(3):175-84. PubMed ID: 1820757
[TBL] [Abstract][Full Text] [Related]
11. Obsessive-compulsive disorder.
Zetin M; Kramer MA
Hosp Community Psychiatry; 1992 Jul; 43(7):689-99. PubMed ID: 1516899
[TBL] [Abstract][Full Text] [Related]
12. Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder.
McDougle CJ; Goodman WK; Leckman JF; Holzer JC; Barr LC; McCance-Katz E; Heninger GR; Price LH
Am J Psychiatry; 1993 Apr; 150(4):647-9. PubMed ID: 8465885
[TBL] [Abstract][Full Text] [Related]
13. Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.
Fineberg NA; Bullock T; Montgomery DB; Montgomery SA
Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():43-7. PubMed ID: 1517558
[No Abstract] [Full Text] [Related]
14. Prazosin addition to fluvoxamine: A preclinical study and open clinical trial in OCD.
Feenstra MGP; Klompmakers A; Figee M; Fluitman S; Vulink N; Westenberg HGM; Denys D
Eur Neuropsychopharmacol; 2016 Feb; 26(2):310-319. PubMed ID: 26712326
[TBL] [Abstract][Full Text] [Related]
15. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
Servant D; Bailly D; Le Seac'h H; Parquet PJ
Encephale; 1990; 16 Spec No():359-62. PubMed ID: 2120029
[TBL] [Abstract][Full Text] [Related]
16. Compulsive exhibitionism successfully treated with fluvoxamine: a controlled case study.
Zohar J; Kaplan Z; Benjamin J
J Clin Psychiatry; 1994 Mar; 55(3):86-8. PubMed ID: 8071253
[TBL] [Abstract][Full Text] [Related]
17. The effects of topiramate adjunctive treatment added to antidepressants in patients with resistant obsessive-compulsive disorder.
Rubio G; Jiménez-Arriero MA; Martínez-Gras I; Manzanares J; Palomo T
J Clin Psychopharmacol; 2006 Jun; 26(3):341-4. PubMed ID: 16702907
[No Abstract] [Full Text] [Related]
18. Serotonin syndrome from fluvoxamine and buspirone.
Baetz M; Malcolm D
Can J Psychiatry; 1995 Sep; 40(7):428-9. PubMed ID: 8548727
[No Abstract] [Full Text] [Related]
19. [The usage of different antidepressants in therapy of obsessive-compulsive disorders].
Granenov GM; Mosolov SN
Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(7):70-4. PubMed ID: 12938660
[No Abstract] [Full Text] [Related]
20. Treatment of severe obsessive-compulsive disorder with fluvoxamine.
Price LH; Goodman WK; Charney DS; Rasmussen SA; Heninger GR
Am J Psychiatry; 1987 Aug; 144(8):1059-61. PubMed ID: 3111279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
